Modulation of IL-1-induced chemokine expression in human mesangial cells through alterations in redox status

Cytokine

Volumn 9, Issue 3, 1997, Pages 178-186

  Rovin, Brad H ^a,b   Dickerson, Jennifer A ^a   Tan, Laura C ^a   Fassler, John ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

IL 1; MCP 1; Mesangial cells; Oxygen radicals

Indexed keywords

ANTIOXIDANT; CHEMOKINE; DIAMIDE; DNA; GLUTATHIONE; GLUTATHIONE DISULFIDE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; MESSENGER RNA; OXIDIZING AGENT; THIOL;

ARTICLE; CONTROLLED STUDY; GENE INDUCTION; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; MESANGIUM CELL; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN TRANSPORT;

EID: 0031106325     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0152     Document Type: Article

References (56)

1. 1. Rovin BH, Yoshiumura T, Tan L (1992) Cytokine induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells. J Immunol 148:2148-2153.
2. 2. Schmouder RL, Streiter RM, Kunkel SL (1993) Interferon-gamma regulation of human renal cortical epithelial cell-derived monocyte chemotactic protein-1. Kidney Int 44:43-49.
3. 3. Kakizaki Y, Sugimoto K, Waga S, Tanaka H, Yokoyama M (1995) Transcription factors NF-kB and AP-1 regulate gene expression of monocyte chemoattractant protein-1 (MCP-1) by bovine glomerular endothelial cells. J Am Soc Nephrol 6:833A.
4. 4. Rovin BH, Rumancik M, Tan L, Dickerson J (1994) Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest 71:536-542.
5. 5. Noris M, Bernasconi S, Casiraghi F, Sozzani S, Gotti E, Remuzzi G, Mantovani A (1995) Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab Invest 73:804-809.
6. 6. Stahl RAK, Thaiss F, Disser M, Helmchen U, Hora K, Schlondorff D (1993) Increased expression of monocyte chemo-attractant protein-1 in anti-thomocyte antibody-induced glomerulo-nephritis. Kidney Int 44:1036-1047.
7. 7. Wu X, Wittwer AJ, Carr LS, Crippes BA, DeLarco JE, Lefkowith JB (1994) Cytokine-induced neutrophil chemoattractant mediates neutrophil influx in immune complex glomerulonephritis in rat. J Clin Invest 94:337-344.
8. 8. Wada T, Tomosugi N, Naito T, Yokoyama H, Kobayashi K-I, Harada A, Mukaida N, Matsushima K. (1994) Prevention of proteinuria by the administation of anti-interleukin 8 antibody in experimental acute immune complex-induced glomerulonephritis. J Exp Med 180:1135-1140.
9. 9. Tang WW, Qi M, Warren JS (1995) The role of monocyte chemoattractant protein-1 (MCP-1) in anti-GBM GN. J Am Soc Nephrol 6:855A.
10. 10. Werber HI, Emancipator SN, Tykocinski ML, Sedor JR (1987) The interleukin 1 gene is expressed by rat glomerular mesangial cells and is augmented in immune complex glomerulo-nephritis. J Immunol 138:3207-3212.
11. 11. Lan HY, Nikolic-Paterson DJ, Mu W, Vannice JL, Atkins RC (1995) Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat. Kidney Int 47:1303-1309.
12. 12. D'Agati VD, Appel GB, Estes D, Knowles DM, Pirani CL (1986) Monoclonal antibody identification of infiltrating mono-nuclear leukocytes in lupus nephritis. Kidney Int 30:573-581.
13. 13. Matsumoto K, Dowling J, Atkins RC (1988) Production of interleukin 1 in glomerular cell cultures from patients with rapidly progressive glomerulonephritis. Am J Nephrol 8:463-470.
14. 14. Diamond JR, Pesek I (1991) Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis: an immunohistochemical study. Lab Invest 64:21-28.
15. 15. Rovin BH, Dickerson JA, Tan LC, Hebert CA (1994) Nuclear factor-kappaB is necessary but not sufficient for IL-1-induced monocyte chemoattractant protein-1 expression by human mesangial cells. J Am Soc Nephrol 5:766A.
16. 16. Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Matsunaga K, Fukushima J, Sawamoto S, Ishigutsubo Y, Obubo T. (1994) NF-kB and Sp1 regulate transcription of the human monocyte chemoattractan protein-1 gene. J Immunol 153:2052-2063.
17. 17. Fakler B, Herlitze S, Amthor B, Zenner H-P, Ruppersberg J-P (1994) Short antisense oligonucleotide-mediated inhibition is strongly dependent on oligo length and concentration but almost independent on location of the target sequence. J Biol Chem 269:16187-16194.
18. 18. Rovin BH, Tan LC (1994) Role of protein kinase pathways in IL-1-induced chemoattractant expression by human mesangial cells. Kidney Int 46:1059-1068.
19. 19. Schieven GL, Kirihara JM, Myers DE, Ledbetter JA, Uckun FM (1993) Reactive oxygen intermediates activate NF-KB in a tyrosine kinase-dependent mechanism and in combination with vanadate activate the p561ck and p59fyn tyrosine kinases in human lymphocytes. Blood 82:1212-1220.
20. 20. Schreck R, Rieber P, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of NF-KB transcription factor and HIV-1. EMBO J 10:2247-2258.
21. 21. Garcia-Ruiz C, Colell A, Morales A, Kaplowitz N, Fernandez-Checa JC (1995) Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappaB: Studies with isolated mitochondria and rat hepatocytes. Mol Pharmacol 48:825-834.
22. 2 potentiates phosphorylation of novel putative substrates for the insulin receptor kinase in intact Fao cells. J Biol Chem 264:10126-10132.
23. 23. Bauskin AR, Alkalay I, Ben-Neriah Y (1991) Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum. Cell 66:685-696.
24. 24. Brennan P, O'Neill LAJ (1995) Effects of oxidants and antioxidants on nuclear factor kB activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. Biochim Biophys Acta 1260:167-175.
25. 25. Israel N, Gougerot-Pocidalo M-A, Aillet F, Virelizier J-L (1992) Redox status of cells influences constitutive or induced NF-kB translocation and HIV long terminal repeat activity in human T and monocyte cell lines. J Immunol 149:3386-3393.
26. 26. Singh S, Aggarwal BB (1995) Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-kB. J Biol Chem 270:10631-10639.
27. 27. Hayashi T, Ueno Y, Okamoto T (1993) Oxidoreductive regulation of Nuclear Factor k B. J Biol Chem 268:11380-11388.
28. 28. Das KC, Lewis-Molock Y, White CW (1995) Thiol modulation of TNFα and IL-1 induced MnSOD gene expression and activation of NF-kB. Mol Cell Biochem 148:45-57.
29. 29. Flescher E, Ledbetter JA, Schieven GL, Vela-Roch N, Fossum D, Dang H, Ogawa N, Talal N (1994) Longitudinal exposure of human T lymphocytes to weak oxidative stress suppresses transmembrane and nuclear signal transduction. J Immunol 153:4880-4888.
30. 30. Kosower NS, Kosower EM (1995) Diamide: An oxidant probe for thiols. Methods Enzymol 251:123-133.
31. 31. Henkel T, Machleidt T, Alkalay I, Kronke M, Ben-Neriah Y, Baeuerle PA (1993) Rapid proteolysis of IkB-a is necessary for activation of the transcription factor NF-kB. Nature 365:182-185.
32. 32. Weber C, Erl W, Pietsch A, Strobel M, Ziegler-Heitbrock HWL, Weber PC (1994) Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kB mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb 14:1665-1673.
33. 33. Staal FJT, Roederer M, Herzenberg LA, Herzenberg LA (1990) Intracellular thiols regulate activation of nuclear factor kB and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 87:9943-9947.
34. 34. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA (1992) Dithiocarbamates as potent inhibitors of nuclear factor kB activation in intact cells. J Exp Med 175:1181-1194.
35. 35. Singh S, Aggarwal BB (1995) Activation of transcription factor NF-kappaB is suppressed by curcumin (diferulolylmethane). J Biol Chem 270:24995-25000.
36. 36. Barchowsky A, Munro SR, Morana SJ, Vincenti MP, Treadwell M (1995) Oxidant-sensitive and phosphorylation-dependent activation of NF-kB and AP-1 in endothelial cells. Am J Physiol Lung Cell Mol Physiol 269:L829-L836.
37. 37. Bradley JR, Johnson DR, Pober JS (1993) Endothelial activation by hydrogen peroxide. Am J Pathol 142:1598-1609.
38. 38. Staal FJT, Roederer M, Herzenberg LA, Herzenberg LA (1990) Intracellular thiols regulate activation of nuclear factor kB and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 87:9943-9947.
39. 39. Menon SD, Qin S, Guy GR, Tan YH (1993) Differential induction of nuclear NF-kB by protein phosphatase inhibitors in primary and transformed human cells. J Biol Chem 268: 26805-26812.
40. 40. Chen ZJ, Parent L, Maniatis T (1996) Site-specific phosphorylation of IkBa by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-862.
41. 41. Matthews JR, Wakasugi N, Virelizier J-L, Yodoi J, Hay RT (1992) Thioredoxin regulates the DNA binding activity of NF-kB by reduction of a disulphide bond involving cysteine 62. Nucleic Acid Res 20:3821-3830.
42. 42. Das KC, Lewis-Molock Y, White CW (1995) Activation of NF-kB and elevation of MnSOD gene expression by thiol reducing agents in lung adenocarcinoma (A549) cells. Am J Physiol (Lung Cell Mol Physiol) 269:L588-L602.
43. 43. Droge W, Schulze-Osthoff K, Mihm S, Galter D, Schenk H, Eck H-P, Roth S, Gmunder H (1994) Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J 8:1131-1138.
44. 44. Mihm S, Galter D, Droge W (1995) Modulation of transcription factor NFkB activity by intracellular glutathione levels and by variations of the extracellular cysteine supply. FASEB J 9:246-252.
45. 45. Galter D, Mihm S, Droge W (1994) Distinct effects of glutathione disulphide on the nuclear transcription factors kB and the activator protein-1. Eur J Biochem 221:639-648.
46. 46. Freeman BA, Crapo JD (1982) Free radicals and tissue injury. Lab Invest 47:412-426.
47. 47. Shah SV (1995) The role of reactive oxygen metabolites in glomerular disease. Annu Rev Physiol 57:245-262.
48. 48. Meister A, Anderson AE (1983) Glutathione. Annu Rev Biochem 52:711-760.
49. 49. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen DE (1993) Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 262:1274-1277.
50. 50. Shan Z, Tan D, Satriano J, Silbiger S, Schlondorff D (1994) Intracellular glutathione influences collagen generation by mesangial cells. Kidney Int 46:388-395.
51. 51. Griffith OW (1980) Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 106:207-212.
52. 52. Buchmuller-Rouiller Y, Corradin SB, Smith J, Schneider P, Ransijn A, Jongeneel CV, Mauel J (1995) Role of glutathione in macrophage activation: Effect of cellular glutathione depletion on nitrite production and leishmanicidal activity. Cell Immunol 164:73-80.
53. 53. Rollins BJ, Stier P, Ernst T, Wong GG (1989) The human homolog of the JE gene encodes a monocyte secretory protein. Mol Cell Biol 9:4687-4695.
54. 54. Baeuerle PA, Henkel T (1994) Function and activation of NF-kB in the immune system. Annu Rev Immunol 12:141-179.
55. 55. Rovin BH, Harris KPG, Morrison A, Klahr S, Scheiner GF (1990) Renal cortical release of a specific macrophage chemoattractant in response to ureteral obstruction. Lab Invest 63:213-220.
56. 56. Kyhse-Andersen J (1984) Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods 10:203-209.